Y Intercept Hong Kong Ltd Acquires 20,684 Shares of Humana Inc. $HUM

Y Intercept Hong Kong Ltd lifted its stake in Humana Inc. (NYSE:HUM) by 332.1% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 26,913 shares of the insurance provider’s stock after buying an additional 20,684 shares during the period. Y Intercept Hong Kong Ltd’s holdings in Humana were worth $7,002,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Revolve Wealth Partners LLC purchased a new stake in Humana in the fourth quarter worth $202,000. Woodline Partners LP lifted its position in shares of Humana by 460.0% in the 1st quarter. Woodline Partners LP now owns 10,192 shares of the insurance provider’s stock worth $2,697,000 after purchasing an additional 8,372 shares during the period. Sivia Capital Partners LLC boosted its stake in shares of Humana by 53.7% during the 2nd quarter. Sivia Capital Partners LLC now owns 1,293 shares of the insurance provider’s stock valued at $316,000 after purchasing an additional 452 shares in the last quarter. Assenagon Asset Management S.A. increased its position in shares of Humana by 2.6% during the second quarter. Assenagon Asset Management S.A. now owns 5,516 shares of the insurance provider’s stock valued at $1,349,000 after buying an additional 138 shares during the period. Finally, U.S. Capital Wealth Advisors LLC bought a new position in Humana in the second quarter worth about $250,000. Institutional investors own 92.38% of the company’s stock.

Humana Stock Performance

Shares of HUM opened at $265.68 on Friday. Humana Inc. has a 12 month low of $206.87 and a 12 month high of $315.35. The business’s fifty day simple moving average is $258.26 and its two-hundred day simple moving average is $264.66. The company has a current ratio of 2.02, a quick ratio of 2.02 and a debt-to-equity ratio of 0.68. The company has a market cap of $31.95 billion, a price-to-earnings ratio of 24.90, a P/E/G ratio of 2.19 and a beta of 0.45.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, November 5th. The insurance provider reported $3.24 EPS for the quarter, topping analysts’ consensus estimates of $2.95 by $0.29. The firm had revenue of $32.65 billion during the quarter, compared to analyst estimates of $31.99 billion. Humana had a net margin of 1.02% and a return on equity of 12.86%. The business’s revenue for the quarter was up 11.1% on a year-over-year basis. During the same period in the previous year, the business posted $4.16 earnings per share. Research analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.3%. The ex-dividend date is Friday, December 26th. Humana’s dividend payout ratio is 33.18%.

Analysts Set New Price Targets

Several analysts have weighed in on the company. Barclays reaffirmed an “underperformer” rating on shares of Humana in a research report on Monday, January 5th. Wolfe Research lifted their price target on shares of Humana from $300.00 to $325.00 and gave the company an “outperform” rating in a research report on Thursday, January 8th. Weiss Ratings reissued a “sell (d+)” rating on shares of Humana in a research note on Thursday. The Goldman Sachs Group decreased their target price on shares of Humana from $235.00 to $215.00 and set a “sell” rating for the company in a research note on Monday, November 24th. Finally, Morgan Stanley reissued an “underperform” rating on shares of Humana in a research report on Thursday, December 18th. Eight equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and five have assigned a Sell rating to the company. According to MarketBeat, Humana currently has a consensus rating of “Hold” and a consensus price target of $293.37.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.